About the Event
Be part of shaping a brighter future for Women's Health!
Join us at Tech4Eva Conference 2024 in person at Agora Cancer Research Center at CHUV Hospital in Lausanne or online from 16:00 - 18:00 pm CET followed by networking drinks from 18:00-19:00 pm CET.
Femtech has gained tremendous momentum over the last 4 years and we continue to see progress in gender equity and advances in innovative solutions improving the quality of life of women every day. We are so proud of our cohort for pushing the boundaries and solving issues in the women's lifecycle from menstruation to menopause - you will hear their pitches during the showcases.
The 2024 hybrid Tech4Eva Conference - in partnership with CHUV and Innovaud is once again bringing together industry stakeholders from around the world, including corporates, investors, entrepreneurs, innovators, academic researchers, students, and ecosystem builders, to discuss the current and future of technologies for women’s health.
This year's conference will focus on the theme of maternal health. Don't miss the keynotes on "AI-assisted solutions for maternity care" and "Clinical research in public health institutions - is it relevant ?" as well as an insightful panel discussion with different stakeholders points of view on maternal health. Scroll down this page to see the full agenda and speaker bios.
🎙️ Meet our confirmed speakers: Dr. Basile Pache of CHUV, Raymon uit de Bulten of Philips, Pascal Koenig of Malaica, Julien Penders of Bloomlife, Lan Zuo Gillet of EPFL Innovation Park, Prof. Antoniya Georgieva of University of Oxford, Mariana Atilano Merinan, Tiziana D’Onofrio and Anna Soederlind of Groupe Mutuel, Stefan Kohler of CHUV, Jerome Michaud of Tech4Eva and Francois Capel of Innovaud.
Why should you attend?
- Gain awareness on the importance of women's health and its impact on society.
- Find Femtech solutions, investments and partnership opportunities.
- Expand your network.
- Meet Femtech start-ups of the global accelerator Tech4Eva's.
- Be inspired to create tomorrow’s innovative solutions
Join us to discover tomorrow’s innovations disrupting the women’s healthcare industry!
Event Speakers
Lan is the Deputy Managing Director of EPFL Innovation Park and an Expert of Innosuisse – the Swiss Innovation Agency. She has 23 years of hands-on professional experience in industry as well as in the ecosystem of innovation & entrepreneurship.
Lan started her career at R&D department of Rolex, in charge of creating new computer aided design and optimisation tools in the product development process. She was later appointed as Head of Operational Planning at Pictet, working closely with a startup to design, develop and implement a management information system for group operation control. As the Managing Director of Geneva Creativity Center, she connected large corporations, SMEs, startups and researchers to initiate innovative joint R&D projects.
Currently at EPFL Innovation Park, she is leading entrepreneurship training and acceleration programs and is helping startups to establish business partnership with large corporations. Lan has a PhD degree from EPFL, an MBA from HEC Lausanne and postdoctoral applied research experience at Stanford University.
Raymon uit de Bulten is an experienced and results-driven leader in new proposition and business creation at Philips. As Director Start-up Ventures he leads a team of cross-functional intrapreneurs in developing new solutions and business models via internal ventures and incubators. Outward looking, creative and forward-thinking; Raymon specializes in bringing together business opportunities, innovation and design to create meaningful consumer solutions.
Pascal studied economics at the University of St. Gallen / Switzerland and Columbia Business School / New York. He started his career as a strategy consultant at McKinsey.
Over the last two decades he built several startups in the digital health space. The last one – Femtech company Ava – grew to a team of 100+ people working on three continents, generating eight digit USD revenue during Pascal’s tenure as CEO.
Pascal’s latest start-up Malaica is on a mission to make the pregnancy journey safe and joyful for millions in lower income countries. Co-founded in 2022 with a team of Kenyan health experts and entrepreneurs, the company is having strong impact and revenue traction.
After a scientific and R&D career in the food and pharma industry with 20 years of experience, Francois is now Innovation advisor for Life Science and Nutrition businesses where is supports and connects companies and projects with the existing ecosystem
Julien Penders is co-founder and COO at Bloomlife, an award-winning women’s health company solving one of the most significant yet underserved global challenges today, maternal health. Bloomlife combines its FDA-cleared prenatal wearable with connected devices and data analytics to increase access to care, provide personalized feedback to moms, and help doctors earlier predict and manage pregnancy complications. Julien is the proud dad of 3 children who were the inspiration to create Bloomlife.
Julien is a passionate entrepreneur, operator, startup mentor and early-stage angel investor with 20-year experience in med-tech, health-tech and digital health. He led international teams through the development of medical devices and digital health products for the cardiac, neurological and wellness industry, with responsibilities covering hardware, software, analytics, clinical, regulatory, manufacturing and commercialization. Julien has (co-)authored over 60 papers and 14 patents. He is a TEDx and EMBS Distinguished Speaker. Julien was a 2004/2005 fellow of the Belgian American Educational Foundation. He holds a M.Sc. degree in Engineering Physics from University of Liege, Belgium (2004), and a M.Sc. degree in Biomedical Engineering from Boston University, MA (2006).
Anna holds a MSc from Stockholm School of Economics, as well as diplomas from the Karolinska Institutet and the Royal Institute of Technology (KTH).
She is passionate about the mix between economics, technology and the human aspect of healthcare.
In her current role she is responsible for the Innovation activities carried out at Groupe Mutuel, aiming to constantly bringing new topics and trends to the table.
Jérôme is an EPFL Alumni, MSc in Material Science Engineering (2011) and CAS in Management of Life Sciences Ventures (2023), Project Management Professional (PMP 2021) and Situational Leadership Trainer (SLII 2022) with 15 years of experience in innovation, operations management, 1 successful exit and two businesses up and running (Augeo Business Coaching and PhenomX Health SA).
Jérôme is currently an active startup coach/mentor at Tech4Eva, FemTechLab, MassChallenge Switzerland and, Co-Founder and Chief Operating Officer of PhenomX Health, an early stage Swiss FemTech startup.
That’s his passion for entrepreneurship that pushes him to create his first company in 2010 while studying and after 5 years and a successful exit, join Procter & Gamble to drive and scale-up innovation. During more than a decade managing corporate innovation Jérôme developed a strong expertise in the consumer goods and healthcare industries, notably managing P&G/Teva Pharmaceuticals JV post dissolution and the integration of Merck consumer health from an end-to-end technical operations point of view.
As a coach and mentor since 2021 Jérôme regularly supports startups and SMEs in the fields of MedTech, Digital Health and BioTech. These activities helped him develop a strong understanding of the Swiss and International startup ecosystem and, network. His fields of expertise include business strategy and operations, portfolio and resources management, digital transformation, organizational design and development, strategic partnerships.
Event Agenda
15:30 Registration & Welcome Coffee at Agora Cancer Research Center - CHUV Lausanne University Hospital
16:00 Welcome Remarks
Masters of Ceremony: Jerome Michaud, Mentor of Tech4Eva and Anna Soederlind, Innovation Expert of Groupe Mutuel
16:05 Tech4Eva Remarks
Speakers: Mariana Atilano Merinan, Head of Strategy & Innovation of Groupe Mutuel and Lan Zuo Gillet, Deputy Managing Director of EPFL Innovation Park and Director of Tech4Eva, and
16:20 Intro & Keynote Speech "Clinical research in public health institutions - is it relevant?" by CHUV
Carrying out relevant clinical research projects, for which you need to find the resources and skills, while at the same time being a clinician and a surgeon, can be challenging : overview and a look ahead.
Speakers: Stefan Kohler, Deputy for Innovation at the Directorate of Innovation and Clinical Research, CHUV and Dr. Basile Pache, Senior Registrar, Gynecology and Obstetrics, Women-Mother-Child Department, Lausanne University Hospital (CHUV)
16:35 Tech4Eva Showcase Tech4Eva Start-ups Group 1
Showcase: Hormona, CareNX Innovations, cc Diagnostics, Calico Biosystems, Babyndex, HeroSupport, Endocure, VivoSens Medical
16:55 Mini Break
17:05 Intro Innovaud
Speaker: Francois Capel, Innovation Advisor Lifescience & Nutrition, Innovaud
17:10 Talk on "AI-assisted risk-assessment in maternity"
Speaker: Antoniya Georgieva, Associate Professor, Nuffield Dep. Women's & Reproductive Health at University of Oxford
17:20 Panel discussion "Advancing Maternal Health Outcomes"
Speakers: Pascal Koenig, Founder, Malaica, Raymon uit de Bulten, Director Pregnancy for Business Lead & B2B Digital Health solution for insurers and payers, Philips, Julien Penders, Co-Founder & COO of Bloomlife and Tiziana D'Onofrio of Groupe Mutuel
Moderator: Antoniya Georgieva, Associate Professor, Nuffield Dep. Women's & Reproductive Health at University of Oxford
17:40 Tech4Eva Showcase Tech4Eva Start-ups Group 2
Showcase: Mamotest, DeepLook Medical, Harmonia Healthcare, Vital Start Health, Cosm Medical, Namida, Sin Reglas, Galena Innovations
18:00 Closing Remarks
Masters of Ceremony: Jerome Michaud, Mentor of Tech4Eva and Anna Soederlind, Innovation Expert of Groupe Mutuel
18:05 Online Event ends
18:00 Networking Closing Drinks at Agora Cancer Research Center - CHUV Lausanne University Hospital
19:00 In person Event ends
Time zone CET, agenda subject to changes